CVR: 42642649
DKK -23,365,247
Gross profit
Net result: DKK -33,781,079
Novo Holdings A/S, Commit Biologics Holding ApS
2 more
CVR · view ownership and management
Director registered: Thomas Lars Andresen
CVR · 16/03/2026
View the full event history
Commit Biologics ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Lars Andresen. The company's owners include Novo Holdings A/S, Commit Biologics Holding ApS and Bioqube Factory Fund I CommV. In 2025, the company reported a gross profit of DKK -23,365,247 and a net result of DKK -33,781,079 compared with DKK -39,360,775 the year before. Equity in the 2025 report amounted to DKK 37,898,027.
Selskabets formål er fremstilling af farmaceutiske præparater, forskning og eksperimentel udvikling indenfor bioteknologi.
Source: annual reports filed with the Danish Business Authority.
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningCommit Biologics ApS was founded on 1 September 2021.
Commit Biologics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
The owners of Commit Biologics ApS include Novo Holdings A/S, Commit Biologics Holding ApS and Bioqube Factory Fund I CommV.
In 2025, Commit Biologics ApS reported a gross profit of DKK -23,365,247.
The management of Commit Biologics ApS consists of Thomas Lars Andresen.
Commit Biologics ApS is located at Universitetsbyen 81, 8000 Aarhus C.
Claim this page to add your logo and social links. Free to get started.
Commit Biologics ApS has published its annual report for 2025. Gross profit came to DKK -23,365,247, and the net result was DKK -33,781,079.
As of March 16, 2026, Thomas Lars Andresen has joined the board of directors of Commit Biologics ApS.
As of March 16, 2026, Mikkel Wandahl Pedersen has left the board of directors of Commit Biologics ApS.
As of March 16, 2026, Thomas Lars Andresen is registered as adm. dir. of Commit Biologics ApS.
As of March 16, 2026, Mikkel Wandahl Pedersen has stepped down as adm. dir. of Commit Biologics ApS.
As of January 8, 2026, Novo Holdings A/S is registered as an owner of Commit Biologics ApS with an ownership share of 25%.
As of January 8, 2026, Commit Biologics Holding ApS is registered as an owner of Commit Biologics ApS with an ownership share of 15%.
As of January 8, 2026, is registered as an owner of Commit Biologics ApS with an ownership share of 25%.
As of January 8, 2026, is registered as an owner of Commit Biologics ApS with an ownership share of 15%.
As of July 10, 2025, Mikkel Wandahl Pedersen has joined the board of directors of Commit Biologics ApS.
Commit Biologics ApS has published its annual report for 2024. Gross profit came to DKK -31,408,009, and the net result was DKK -39,360,775.
As of January 11, 2025, Krishna Reddy Polu has left the board of directors of Commit Biologics ApS.
As of January 11, 2025, Mikkel Wandahl Pedersen is registered as adm. dir. of Commit Biologics ApS.
As of January 11, 2025, Krishna Reddy Polu has stepped down as adm. dir. of Commit Biologics ApS.
As of December 23, 2024, Eva Van Overmeire has joined the board of directors of Commit Biologics ApS.
As of December 23, 2024, Janine Schuurman has joined the board of directors of Commit Biologics ApS.
Commit Biologics ApS has published its annual report for 2023. Gross profit came to DKK -13,580,251, and the net result was DKK -17,295,813.
As of August 24, 2023, Krishna Reddy Polu has joined the board of directors of Commit Biologics ApS.
As of August 24, 2023, Krishna Reddy Polu is registered as adm. dir. of Commit Biologics ApS.
As of August 24, 2023, Nick Stub Laursen has stepped down as director of Commit Biologics ApS.
Commit Biologics ApS has published its interim report for the period September 1, 2021 – December 31, 2022.
As of February 1, 2023, Anker Gunvald Lundemose has joined the board of directors of Commit Biologics ApS.
As of January 31, 2023, KOVSTED & SKOVGÅRD, REVISION & RÅDGIVNING, STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Commit Biologics ApS.
As of December 30, 2022, Pieter Jeroen Bakker has joined the board of directors of Commit Biologics ApS.
As of December 30, 2022, Nick Stub Laursen has joined the board of directors of Commit Biologics ApS.
As of December 30, 2022, Roderick Verhelst has joined the board of directors of Commit Biologics ApS.
As of December 30, 2022, Dennis Vestergaard Pedersen has stepped down as director of Commit Biologics ApS.
As of December 30, 2022, Heidi Gytz Olesen has stepped down as director of Commit Biologics ApS.
As of December 30, 2022, Mikael Becher Lykkegaard Winkler has stepped down as director of Commit Biologics ApS.
As of September 1, 2021, Nick Stub Laursen is registered as director of Commit Biologics ApS.
As of September 1, 2021, Dennis Vestergaard Pedersen is registered as director of Commit Biologics ApS.
As of September 1, 2021, Heidi Gytz Olesen is registered as director of Commit Biologics ApS.
As of September 1, 2021, Mikael Becher Lykkegaard Winkler is registered as director of Commit Biologics ApS.
Commit Biologics ApS was founded on September 1, 2021.
Companies in the same industry and area
CVR 40394591
CVR 37724157
CVR 43574736
CVR 45124606
CVR 46274199
